The antibody–drug conjugate ifinatamab deruxtecan (I-DXd) showed clinically meaningful responses in pretreated patients with extensive-stage small cell lung cancer (ES-SCLC),…
Despite significant improvements in the perception of biomarker testing compared to a 2018 survey, substantial barriers to implementation persist globally,…
FlexM launches FlexComply, a cloud-based platform to simplify KYC compliance for financial institutions, reducing costs and improving customer onboarding efficiency.…